BetaEntity Annotation Prototype
← Back to funders

Annotated abstract

Effectiveness of SMS reminders to increase demand for HPV immunisation: a randomised controlled trial in Georgia

bmjopen · 2025-11-13 · canonical JSON source

7 visible annotations · policy: published · automated confidence ≥ 75.00%

Document resource

Objective To assess the effects of behaviourally informed short message service (SMS) reminders on demand for human papillomavirus (HPV) immunisation.Design Individually randomised, five-group, controlled parallel trial.Setting A country-wide trial in Georgia.Participants 55 176 girls aged 10–12, the entire population of unvaccinated girls of this age in the country, for whom there existed caregiver contact details.Intervention Girls were randomised into five arms (four with n=11 035, with one n=11 036). Caregivers of the girls in four of the arms (treatment groups) were sent different versions of an SMS reminder (SMSR), reminding them that the girl was due to receive the HPV vaccine. The control group was sent no SMSR.Outcome The primary outcome was a girl’s HPV vaccination status at the end of the trial.Blinding Girls and their caregivers were blinded to group assignment.Numbers analysed The number of participants analysed in the four treatment groups was 10,784, 10,802, 10,794 and 10,820, with 10 828 analysed in the control group.Results Each of the SMSRs was more effective than the control (no reminder) in encouraging HPV vaccination. Girls whose caregiver(s) were sent version 3 had 65% greater odds of receiving the vaccine relative to the control group (OR=1.65; 95% CI 1.38 to 1.97). Among girls whose caregivers received version 1, version 2 and version 4 of the SMS, the odds of receiving the HPV vaccine were respectively 42% (OR=1.42; 95% CI 1.18 to 1.70), 34% (OR=1.34; 95% CI 1.12 to 1.61) and 35% (OR=1.35; 95% CI 1.13 to 1.62) higher compared with the girls in the control arm.Conclusions We find a positive and statistically significant effect for each version of the SMSR, relative to the control condition.Trial registration number NCT05536674.